The Use of Lithium Carbonate to Reduce Infection and Leukopenia during Systemic Chemotherapy
- 31 January 1980
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (5) , 257-260
- https://doi.org/10.1056/nejm198001313020503
Abstract
To investigate whether lithium ameliorates the infectious complications that accompany systemic chemotherapy, we studied 45 patients with small-cell bronchogenic carcinoma receiving combination chemotherapy and radiation therapy. Twenty received lithium carbonate, and 25 received no additional therapy.This publication has 20 references indexed in Scilit:
- Enhancement of lymphocyte and macrophage function in vitro by lithium chlorideClinical Immunology and Immunopathology, 1978
- Combination Chemotherapy and Radiation Therapy of Undifferentiated Small Cell Bronchogenic CarcinomaSouthern Medical Journal, 1978
- Effect of Lithium on Neutrophil Mass and ProductionNew England Journal of Medicine, 1978
- Attenuation of Myelosuppression with LithiumNew England Journal of Medicine, 1977
- Lithium Carbonate Attenuation of Chemotherapy-Induced NeutropeniaNew England Journal of Medicine, 1977
- Effect of Lithium Carbonate on the Neutropenia Caused by Chemotherapy: A Preliminary Clinical TrialOncology, 1977
- SMALL-CELL CARCINOMA OF THE LUNG: ATTEMPT TO REMEDY CAUSES OF PAST THERAPEUTIC FAILUREThe Lancet, 1976
- MEDICAL RESEARCH COUNCIL COMPARATIVE TRIAL OF SURGERY AND RADIOTHERAPY FOR PRIMARY TREATMENT OF SMALL-CELLED OR OAT-CELLED CARCINOMA OF BRONCHUSThe Lancet, 1973
- Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamideCancer, 1972
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945